Laurent Tessonnier

1.5k total citations
23 papers, 424 citations indexed

About

Laurent Tessonnier is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Laurent Tessonnier has authored 23 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Laurent Tessonnier's work include Cancer, Hypoxia, and Metabolism (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Laurent Tessonnier is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Pituitary Gland Disorders and Treatments (4 papers). Laurent Tessonnier collaborates with scholars based in France, Switzerland and Italy. Laurent Tessonnier's co-authors include O. Mundler, David Taïeb, F. Sébag, J. F. Henry, C. De Micco, Fausto Palazzo, Isabelle Morange, C. Colavolpe, B. Conte‐Devolx and Julien Mancini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Laurent Tessonnier

20 papers receiving 411 citations

Peers

Laurent Tessonnier
S. Gabriel France
Laurent Tessonnier
Citations per year, relative to Laurent Tessonnier Laurent Tessonnier (= 1×) peers S. Gabriel

Countries citing papers authored by Laurent Tessonnier

Since Specialization
Citations

This map shows the geographic impact of Laurent Tessonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Tessonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Tessonnier more than expected).

Fields of papers citing papers by Laurent Tessonnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Tessonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Tessonnier. The network helps show where Laurent Tessonnier may publish in the future.

Co-authorship network of co-authors of Laurent Tessonnier

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Tessonnier. A scholar is included among the top collaborators of Laurent Tessonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Tessonnier. Laurent Tessonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Philip, Mary, Laurent Tessonnier, Julien Mancini, et al.. (2019). 333018F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography (PET/CT) for the diagnosis of prosthetic valve infective endocarditis (PVIE): a prospective multicenter study. European Heart Journal. 40(Supplement_1). 2 indexed citations
2.
Ferrara, Roberto, Laura Mezquita, Matthieu Texier, et al.. (2019). Fast-progression (FP), hyper-progression (HPD) and early deaths (ED) in advanced non-small cell lung cancer (NSCLC) patients (pts) upon PD-(L)-1 blockade (IO).. Journal of Clinical Oncology. 37(15_suppl). 9107–9107. 13 indexed citations
3.
Ferrara, Roberto, Caroline Caramella, Matthieu Texier, et al.. (2017). Hyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO). Annals of Oncology. 28. v464–v465. 19 indexed citations
4.
Mezquita, Laura, Édouard Auclin, Roberto Ferrara, et al.. (2017). Baseline-derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) to predict the benefit of immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients.. Journal of Clinical Oncology. 35(15_suppl). 9089–9089. 4 indexed citations
5.
Melenotte, Cléa, Nadim Cassir, Laurent Tessonnier, & Philippe Brouqui. (2015). Atypical measles syndrome in adults: still around. BMJ Case Reports. 2015. bcr2015211054–bcr2015211054. 18 indexed citations
6.
Tessonnier, Laurent, et al.. (2013). Que peut-on attendre des nouvelles techniques de médecine nucléaire dans le bilan local du cancer du sein ?. Imagerie de la Femme. 23(2). 126–130.
7.
Rossi, P., Laurent Tessonnier, Y. Francès, O. Mundler, & B. Granel. (2012). 99mTc DPD Is the Preferential Bone Tracer for Diagnosis of Cardiac Transthyretin Amyloidosis. Clinical Nuclear Medicine. 37(8). e209–e210. 7 indexed citations
8.
Melenotte, Cléa, B. Granel, Laurent Tessonnier, Jacques Serratrice, & Pierre Jean Weiller. (2012). Rosai‐Dorfman Disease Initially Misdiagnosed as Sarcoidosis. Arthritis & Rheumatism. 65(4). 1136–1136. 3 indexed citations
10.
Taïeb, David, et al.. (2012). Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls. SHILAP Revista de lepidopterología. 11(1). 7–11. 16 indexed citations
11.
Tessonnier, Laurent, C. Ansquer, Claire Bournaud, et al.. (2012). 18F‐FDG Uptake at Initial Staging of the Adrenocortical Cancers: A Diagnostic Tool but Not of Prognostic Value. World Journal of Surgery. 37(1). 107–112. 26 indexed citations
12.
Taïeb, David, Laurent Tessonnier, & O. Mundler. (2010). Imagerie moléculaire nucléaire des paragangliomes. Médecine Nucléaire. 34(8). 451–456.
13.
Tessonnier, Laurent, F. Sébag, C. Ghander, et al.. (2009). Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia. The Journal of Clinical Endocrinology & Metabolism. 95(1). 303–307. 66 indexed citations
14.
Taïeb, David, F. Sébag, Anne Barlier, et al.. (2009). 18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?. Journal of Nuclear Medicine. 50(5). 711–717. 93 indexed citations
15.
Taïeb, David, et al.. (2009). Traitement ablatif par iode. Médecine Nucléaire. 33(5). 314–314. 1 indexed citations
16.
Fakhry, Nicolas, Laurent Tessonnier, Robin Gras, et al.. (2009). Management of cervical lymph node recurrence of melanoma of the head and neck.. PubMed. 130(4-5). 211–4. 1 indexed citations
17.
Tessonnier, Laurent, F. Sébag, Fausto Palazzo, et al.. (2008). Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?. European Journal of Nuclear Medicine and Molecular Imaging. 35(11). 2018–2025. 78 indexed citations
18.
Taïeb, David, Laurent Tessonnier, F. Sébag, et al.. (2008). The role of 18F‐FDOPA and 18F‐FDG–PET in the management of malignant and multifocal phaeochromocytomas. Clinical Endocrinology. 69(4). 580–586. 67 indexed citations
19.
Tessonnier, Laurent, Eric Guedj, Aline Cano, et al.. (2008). Multiple Distal Pulmonary Arterial Thromboses Revealed by Lung Scintigraphy in a Patient With Homocystinuria and Normal Multidetector CT Pulmonary Angiography. Clinical Nuclear Medicine. 34(1). 42–43. 1 indexed citations
20.
Tessonnier, Laurent, Nicolas Fakhry, David Taïeb, Antoine Giovanni, & O. Mundler. (2008). False‐Positive Finding on FDG‐PET/CT after Injectable Elastomere Implant (Vox Implant) for Vocal Cord Paralysis. Otolaryngology. 139(5). 738–739. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026